文献速递治疗药物监测与药物基因组学特殊人群用药

圣犹大儿童研究医院PGY2临床药物基因组学住院药师培训项目的开发

Development of a postgraduate year 2 pharmacy residency in clinical pharmacogenetics.
PubMed 文献 · Am J Health Syst Pharm · 2017-01-01

本文描述了圣犹大儿童研究医院依据ASHP高级实践住院药师标准创建的12个月PGY2临床药物基因组学住院药师培训项目的结构与开发。该项目旨在培养住院药师在临床实践中实施药物基因组学检测的能力,自2012年首位住院药师毕业以来每年毕业1人,毕业生已在学术医疗中心和社区医院从事药物基因组学工作。

要点

  • 12个月PGY2项目依据ASHP高级实践住院药师标准开发
  • 培养住院药师独立实施药物基因组学检测和精准用药能力
  • 毕业生可胜任学术医疗中心或社区医院的药物基因组学岗位

核心结论

  • 圣犹大儿童研究医院于2013年成功开发了PGY2临床药物基因组学住院药师培训项目,毕业生具备推动精准医学和领导药物基因组学检测实施的临床技能与经验。

研究设计与样本

  • 该项目为12个月PGY2临床药物基因组学住院药师培训,依据ASHP高级实践住院药师标准在圣犹大儿童研究医院创建。
  • 自2012年首位住院药师毕业以来,项目每年毕业1名住院药师。

主要发现

  • 项目帮助住院药师发展药物基因组学科学专长,并理解转化研究、创新药学实践模式开发和临床信息学。
  • 住院药师在多学科团队中工作,团队成员包括医师、护士、信息学专家、药师和临床实验室人员。
  • 毕业生已在主要学术医疗中心和社区医院接受药物基因组学职位,以及以药物基因组学为重点的学术和研究职位。

临床怎么用

  • 住院药师通过提供循证、以患者为中心的精准医学服务优化患者结局,作为跨专业团队的核心成员。
  • 项目旨在使住院药师毕业后能够独立在其他医疗系统环境中实施药物基因组学检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The structure and development of an innovative, ASHP-accredited postgraduate year 2 (PGY2) clinical pharmacogenetics residency program are described. SUMMARY: A 12-month PGY2 clinical pharmacogenetics residency was created at St. Jude Children's Research Hospital in accordance with the ASHP standards for advanced practice residencies. The purpose of this 12-month residency program is to prepare pharmacy residents to implement pharmacogenetics in clinical practice. The program helps residents develop expertise in the science of pharmacogenetics as well as an understanding of translational research, innovative pharmacy practice model development, and clinical informatics. The resident learns to optimize patient outcomes through the expert provision of evidence-based, patient-centered precision medicine as an integral part of an interprofessional team. After completing the program, residents are expected to have the clinical skills necessary to practice in the field of clinical pharmacogenetics and independently implement pharmacogenetic testing in other health-system settings. Because implementation of pharmacogenetics requires collaboration across many disciplines, residents works within an interprofessional team of physicians, nurses, informatics specialists, pharmacists, and clinical laboratory personnel to achieve program goals. Since the first resident graduated in 2012, the program has graduated 1 resident each year. Graduated residents have accepted pharmacogenetics positions at major academic medical centers and community hospitals, as well as academic and research positions with a pharmacogenetics emphasis. CONCLUSION: A PGY2 clinical pharmacogenetics residency was successfully developed at St. Jude in 2013. After completion of the program, residents are equipped with the clinical skills and necessary experience to drive precision medicine forward and lead the implementation of pharmacogenetic testing in other healthcare settings.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Haidar CE, Hoffman JM, Gammal RS, et al. Development of a postgraduate year 2 pharmacy residency in clinical pharmacogenetics. Am J Health Syst Pharm. 2017. PMID: 28274984. doi:10.2146/ajhp160174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。